FDA Approves Teva’s Generic Version of Flomax

This add one more generic version of Flomax available that will be available for sale almost immediately. BD

The Food and Drug Administration granted marketing approval Wednesday to Teva Pharmaceutical Industries for a generic version of Flomax, a drug used to treat enlarged prostate.

Flomax is prescribed to treat benign prostatic hyperplasia, a condition characterized by an increase in the size of the prostrate in middle-aged and elderly men that causes slow or blocked urine flow.

Teva is launching its generic product Wednesday.

The branded product generates annual sales of approximately $2 billion for Boehringer Ingelheim, of Ingelheim, Germany, in the United States.